ARTICLE | Financial News
GeneScan revenue warning
September 20, 2001 7:00 AM UTC
Biotech supply and service play GeneScan (NMarkt:GEP) warned investors that its sales have fallen short of its forecast by 25%. The company announced at its IPO in 2000 that sales would rise by some 6...